21 May 2013
Keywords: roche, invests, 389m, germany, switzerland, swiss, drug
Article | 28 January 2008
Swiss drug major Roche has approved extensive 430.0 million Swiss francs ($389.4 million) investment plans for its Penzberg and Mannheim sites in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 January 2008
20 May 2013
© 2013 thepharmaletter.com